Cost and Quality

"Cost and Quality" Main

Latest Morning Briefing Stories

House Approves Permanent Fix For Medicare Doctor Payments

KFF Health News Original

For more than a decade, doctors who treat Medicare patients have been threatened with pay cuts due to a faulty formula of how doctors are reimbursed. But in a rare bipartisan agreement, the House of Representatives overwhelmingly passed a deal to permanently end the problem and reward quality of care, not quantity.

Battle Over Dementia Drug Swap Has Big Stakes For Drugmakers, Consumers

KFF Health News Original

A court ruling about Actavis’s strategy to switch consumers from its top-selling dementia drug, which will lose patent protection this summer, to a newer, patent-protected drug, may define how far drugmakers can go to protect profits from generic rivals.

In Texas Funding Fight, Cancer Care For Poor Women Could Be Collateral Damage

KFF Health News Original

GOP lawmakers eager to cut off funding to Planned Parenthood are weighing changes to a cancer screening program for poor women. But private clinics unaffiliated with Planned Parenthood say they’d take a hit, too.

Retail Health Care Spurs Innovation In South Florida

KFF Health News Original

In September, Florida Blue will debut three “integrated care” facilities designed to cater to South and Central American populations by offering primary care, specialty services, labs and diagnostics under one roof — a model common in Latin America.

Mental Health Providers Look For Federal Incentives To Go Digital, Too

KFF Health News Original

The federal government is spending $26 billion to get doctors and hospitals to move to digital records to help coordinate care, but the funding does not include mental health clinics, psychologists and psychiatric hospitals.

FDA Heads Into Uncharted Territory Of ‘Biosimiliar’ Drugs

KFF Health News Original

Under a new process set out by the health law, the FDA approved the first so-called biosimilar drug for sale in the U.S. It’s a copy of the cancer medicine Neupogen that will be sold under the brand name Zarxio.

What’s At Stake As Health Law Lands At Supreme Court Again

KFF Health News Original

With a $400 tax credit, Julia Raye of North Carolina has been able to afford health insurance and keep her diabetes under control. She is one of 8.2 million people who could lose that subsidy in a case that goes before the U.S. Supreme Court Wednesday.

Internists Get A Break From Controversial Efforts To Bolster Performance

KFF Health News Original

The American Board of Internal Medicine, responding to complaints from doctors, steps back from plans for new standards for physicians’ board recertification, but consumer advocates stress that the board needs to keep focused on patients’ health.

Attention, Shoppers: Prices For 70 Health Care Procedures Now Online!

KFF Health News Original

Guroo.org shows the average local cost of 70 common diagnoses and medical tests in most states. That’s the real cost — not “charges” that often get marked down — based on a giant database of what insurance companies actually pay.

Kaiser Permanente Faulted Again For Mental Health Care Lapses In California

KFF Health News Original

Following up on a critical report in 2013, the California Department of Managed Health Care found Kaiser Permanente had not resolved concerns about providing timely and appropriate access to treatment.